Know2eat

AHCC

Medicinal Mushrooms

What ahcc may help with

Ranked by how strong the human evidence is — best supported first.

Best supportedImmune functionLimited evidence· 4 sources

Then, in order

About AHCC

A proprietary extract of shiitake mycelium cultured in liquid and partially digested with enzymes, characterised by low-molecular-weight alpha-glucans rather than the beta-glucans of ordinary mushroom extracts. It is a single company's product.

AHCC is unusual among mushroom supplements in having a defined manufacturing process, a single manufacturer and a set of registered clinical trials — most of them funded by that manufacturer. The most discussed is a small randomised trial in women with persistent high-risk human papillomavirus infection, in which more women in the AHCC arm had cleared the virus after six months than in the placebo arm. It was a phase II study with about fifty participants, and the finding awaits confirmation in a larger independent trial. There is also a practical safety point that gets less attention than it deserves: AHCC has been shown to alter the metabolism of some drugs.

Sold as
Capsule, Powder sachet
Standardised to
A proprietary preparation defined by its manufacturing process; alpha-glucan content is the characterising measure — a product without this marker may not resemble what was studied.
Also known as
Active hexose correlated compound, Cultured shiitake mycelia extract, AHCC ImmPower

Regulation: Sold as a dietary supplement in the US, Japan and elsewhere with no pre-market efficacy review, while being studied under registered trial protocols. No regulator has approved it for any indication.

What the research used

The amounts, forms and durations published trials of AHCC actually administered.

These are the amounts published trials administered — not a recommendation, and not a dose to copy. Trial participants were screened, supervised and given a characterised preparation. What is in a retail bottle is frequently not what was studied, and the amount that suits one person is not general advice.

  • Studied for Persistent high-risk HPV infection

    3000 mg

    Limited

    Capsule, once daily on an empty stomach · 6 months

    The dose in the phase II trial, which enrolled around fifty women and was supported by the manufacturer. Confirmation in a larger independent trial has not been published.

  • Studied for Immune parameter and supportive-care studies

    1000–3000 mg

    Not enough

    Capsule, daily · 4 weeks to 6 months

    Doses in small studies measuring natural killer cell activity, vaccine response and chemotherapy tolerance. Most are small, several are open-label and manufacturer involvement is the norm.

This is general information about food, not medical advice. It cannot diagnose, treat or replace guidance from a clinician who knows your history.

When it was taken

Each window says whether a trial compared it against an alternative, or whether it is convention and pharmacology. Most timing advice is the second kind.

None of the timings below were directly compared in a trial. They reflect how the research happened to dose, or what the pharmacology implies — which is not the same as a timing being better.

  • On an empty stomach

    Limited

    The HPV trial dosed it on an empty stomach, and the manufacturer advises the same. Whether food changes absorption of the active fraction has not been published as a comparison.

    Timing was not directly compared. This reflects convention or how the compound behaves in the body, not a trial showing this window works better.

The evidence in depth

Best supported: Limited

What each association actually rests on, and the papers behind it. A rating describes the state of the research, not how promising the supplement sounds. How we rate evidence.

Immune function

Immune Health
Limited evidence

A small randomised phase II trial reported higher rates of clearance of persistent high-risk HPV infection after six months compared with placebo. It is one manufacturer-supported study of about fifty women and has not been independently replicated. Other immune outcomes rest on small open studies.

What may be going on: AHCC contains partially hydrolysed alpha-glucans that appear to modulate innate immune signalling, including natural killer cell and dendritic cell activity in laboratory work.

Limited evidence. Early human work, or mostly lab and animal research.

View the 4 sources

Deep research mode adds each paper’s own conclusion and stated limitations.

Liver markers

Liver Health
Not enough evidence

Studies in hepatitis and in liver cancer patients are small, mostly Japanese and largely uncontrolled. There is not enough evidence to support a liver claim.

Not enough evidence. Not enough human research to say anything useful yet.

View the 4 sources

Deep research mode adds each paper’s own conclusion and stated limitations.

Things to know

Interactions, contraindications and dose limits, most serious first. Concentrated extracts interact with medication in ways the whole plant does not, so this section carries more weight here than it does on a food page.

  • Interaction

    Alters the metabolism of some medicines

    Interacts withCYP2D6 and CYP3A4 substrates, chemotherapy agents

    Human and animal studies have found AHCC changes the clearance of drugs metabolised by cytochrome P450 enzymes, including a reported effect on CYP2D6 substrates. Anyone on medication with a narrow therapeutic range, and particularly anyone on cancer therapy, should not add it without pharmacy input.

  • Worth knowing

    Nearly all the evidence comes from one company

    AHCC is a single proprietary product and the great majority of its trials are funded or conducted by its manufacturer. That does not make the results wrong; it does mean independent replication is the thing to wait for, and the HPV finding in particular is a single phase II result.

  • Avoid

    Immunosuppression and transplant

    Interacts withCiclosporin, tacrolimus, immunotherapy

    An immunomodulating extract is a poor combination with transplant immunosuppression or with immune checkpoint therapy, where the direction of any interaction is unknown.

  • Too much

    Digestive effects, itching and foot cramps

    Nausea, diarrhoea, bloating, itching and foot cramps have been reported in trials, generally mild and settling with continued use or a lower dose.

In the food catalogue

The whole-food form, where one exists. The evidence for a concentrated extract rarely transfers to the food, or the other way round — these are cross-links, not equivalents.

Shiitake mushroomsThe species whose mycelium is cultured to make the extract, though…

Evidence ratings on this page: 1 limited evidence, 1 not enough evidence.

Supplements are sold in the US without pre-market review of efficacy or safety. Nothing on this page is a recommendation to take AHCC, or a dose to follow.